XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Unaudited Condensed Consolidated Statements of Comprehensive Loss - EUR (€)
€ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating expenses        
Research and development expenses € (12,497) € (5,031) € (20,192) € (10,505)
General and administrative expenses (3,648) (3,161) (6,949) (6,158)
Total operating expenses (16,145) (8,192) (27,141) (16,663)
Other income 3 65 68 150
Other expenses (79) (21) (83) (33)
Operating result (16,221) (8,148) (27,157) (16,545)
Finance income 1,339 5,742 2,498 6,007
Finance costs (388) (37) (450) (2,226)
Net financial result 950 5,705 2,048 3,781
Loss for the period € (15,271) € (2,443) € (25,109) € (12,764)
Share information        
Weighted average number of shares outstanding (in thousands) 25,964 24,890 25,964 24,357
Loss per share in Euro, basic € (0.59) € (0.10) € (0.97) € (0.52)
Loss per share in Euro, diluted € (0.59) € (0.10) € (0.97) € (0.52)
Loss for the period € (15,271) € (2,443) € (25,109) € (12,764)
Other comprehensive income that may be reclassified to profit or loss in subsequent periods:        
Exchange differences on translation of foreign currency (1,622) (17) 695 (16)
Total comprehensive loss € (16,893) € (2,460) € (24,413) € (12,780)